Publications

2002

Ince TA, Cviko AP, Quade BJ, Yang A, McKeon FD, Mutter GL, et al. p63 Coordinates anogenital modeling and epithelial cell differentiation in the developing female urogenital tract. Am J Pathol. 2002;161(4):1111-7.
Korkmaz KS, Elbi C, Korkmaz CG, Loda M, Hager GL, Saatcioglu F. Molecular cloning and characterization of STAMP1, a highly prostate-specific six transmembrane protein that is overexpressed in prostate cancer. J Biol Chem. 2002;277(39):36689-96.
Ponting CP, Ito T, Moscat J, Diaz-Meco MT, Inagaki F, Sumimoto H. OPR, PC and AID: all in the PB1 family. Trends Biochem Sci. 2002;27(1):10.
Winter WE, Kucera PR, Rodgers W, McBroom JW, Olsen C, G Maxwell L. Surgical staging in patients with ovarian tumors of low malignant potential. Obstet Gynecol. 2002;100(4):671-6.
Bai Y, Fu S, Honig S, Wang Y, Qin L, Chen D, et al. CD2 is a dominant target for allogeneic responses. Am J Transplant. 2002;2(7):618-26.
Oh WK, Loda M, Kantoff PW, Janicek M. Progressive sclerosis of isolated foot metastasis of prostate cancer. J Urol. 2002;167(3):1392.
Hendricks CA, Razlog M, Matsuguchi T, Goyal A, Brock AL, Engelward BP. The S. cerevisiae Mag1 3-methyladenine DNA glycosylase modulates susceptibility to homologous recombination. DNA Repair (Amst). 2002;1(8):645-59.
Osipov V, Keating JT, Faul PN, Loda M, Datta MW. Expression of p27 and VHL in renal tumors. Appl Immunohistochem Mol Morphol. 2002;10(4):344-50.
Singh D, Febbo PG, Ross K, Jackson DG, Manola J, Ladd C, et al. Gene expression correlates of clinical prostate cancer behavior. Cancer Cell. 2002;1(2):203-9.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700